CMP Pharma is a specialty pharmaceutical company that addresses critical needs for niche markets within the pharmaceutical and life science industries by developing and manufacturing a portfolio of high value semi-solid and liquid products. Our products include leading, high-quality branded and generic prescription, non-prescription and skin care pharmaceutical products, which we distribute to hospital, long-term care, and retail channels.
The History of CMP Pharma
CMP Pharma was founded by Henry Smith as Carolina Medical Products (CMP) Company in 1975 while he was a professor of drug manufacturing at the University of North Carolina at Chapel Hill’s School of Pharmacy. In 1982, CMP’s, SPS® Suspension was the first FDA approved suspension form of Sodium Polystyrene Sulfonate for the treatment of hyperkalemia. Prior to this approval, Sodium Polystyrene Sulfonate was only available as a powder for suspension.
Approvals followed for Isoniazid Oral Solution, USP, the only FDA approved liquid treatment for tuberculosis, as well as Hydrocortisone 1% in Absorbase®, Triamcinolone Acetonide 0.05% in Absorbase®, Sodium Polystyrene Sulfonate for Suspension, and Amantadine Hydrochloride Oral Solution.
Other products include:
- Oracit® – a treatment for metabolic conditions
- Dermacloud Ointment – an OTC skin protectant
- Absorbase® – a non-prescription topical ointment for dry skin conditions
- Simethicone Drops – an OTC agent for relief of symptoms associated with gas in the digestive tract
We’ve manufactured high-quality pharmaceutical products at our Farmville, North Carolina facility since 1986.